Morrow, OH, United States of America

Wilfredo Morales

This inventor holds 5 USPTO granted patents. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wilfredo Morales. Retrieved from https://idiyas.com/inventor/wilfredo-morales

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Wilfredo Morales

Introduction

Wilfredo Morales is a notable inventor based in Morrow, Ohio, with a focus on pharmaceutical innovations. He holds a total of four patents, showcasing his contributions to the field of drug formulation and delivery systems.

Latest Patents

Among his latest patents is a crystallization process for aripiprazole derivatives in extended release formulations aimed at treating schizophrenia. This patent details processes for providing depot injections of recrystallized aripiprazole lauroxil, where the particles have a surface area ranging from about 0.50 to about 3.3 m/g. Additionally, he has developed crystals of aripiprazole lauroxil produced by these innovative processes.

Career Highlights

Wilfredo Morales is currently associated with Alkermes Pharma Ireland Limited, where he applies his expertise in pharmaceutical development. His work significantly contributes to advancements in treatment options for mental health conditions.

Collaborations

He collaborates with esteemed colleagues such as Tarek A. Zeidan and Renato A. Chiarella, further enhancing the innovative environment at his workplace.

Conclusion

Wilfredo Morales exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for improved treatment methodologies. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…